INS and metabolic disease: Indeed, the loss of microbial richness and the predominance of pathogenic bacteria, commonly observed in metabolic disorders, are thought to take part in low-grade metabolic inflammation, establishing a source of sustenance for pathological processes such as insulin resistance and vascular dysfunction [50].